論文（英文）
Mishima H, Oba K, Sakamoto J, Muro K, Yoshino T, Hyodo I, Maehara Y. Bevacizumab-containing therapy (5 mg/kg or 10 mg/kg) and FOLFIRI in advanced colorectal cancer failed to bevacizumab plus oxaliplatin-based therapy: A Phase III Study (EAGLE Study). Jpn J Clin Oncol 2011;42(2):134-8.
Mishima H, Oba K, Sakamoto J, Muro K, Yoshino T, Hyodo I, Maehara Y. Bevacizumab-containing therapy (5 mg/kg or 10 mg/kg) and FOLFIRI in advanced colorectal cancer failed to bevacizumab plus oxaliplatin-based therapy: A Phase III Study (EAGLE Study). Jpn J Clin Oncol 2011;42(2):134-8.